These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 12604865)
1. Therapeutic monitoring of class I antiarrhythmic agents using high-resolution electrocardiography instead of blood samples. Sutovsky I; Katoh T; Takayama H; Ono T; Takano T Circ J; 2003 Mar; 67(3):195-8. PubMed ID: 12604865 [TBL] [Abstract][Full Text] [Related]
2. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects. Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547 [TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic and hemodynamic effects of a single oral dose of pilsicainide hydrochloride, a new class 1c antiarrhythmic agent. Ino T; Atarashi H; Kuruma A; Onodera T; Saitoh H; Hayakawa H J Cardiovasc Pharmacol; 1998 Jan; 31(1):157-64. PubMed ID: 9456290 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of pilsicainide hydrochloride for injection in healthy Chinese volunteers: a randomized, parallel-group, open-label, single-dose study. Qiu Q; Liu W; Li J; Wei Y; Yang K; Suo W; Wu W; Du H; Zhang Y; Zhao G; Zhou Z; Zheng Y; Lin Y Clin Ther; 2014 Feb; 36(2):255-63. PubMed ID: 24480637 [TBL] [Abstract][Full Text] [Related]
5. Determination of oral dosage and pharmacokinetic analysis of flecainide in horses. Ohmura H; Hiraga A; Aida H; Takahashi T; Nukada T J Vet Med Sci; 2001 May; 63(5):511-4. PubMed ID: 11411495 [TBL] [Abstract][Full Text] [Related]
6. Ischemia enhances use-dependent sodium channel blockade by pilsicainide, a class IC antiarrhythmic agent. Sadanaga T; Ogawa S J Am Coll Cardiol; 1994 May; 23(6):1378-81. PubMed ID: 8176096 [TBL] [Abstract][Full Text] [Related]
7. [Effect of class I anti-arrhythmia agents on the signal-averaged ECG]. Goedel-Meinen L; Hofmann M; Schmidt G; Barthel P; Baedeker W; Blömer H Herz; 1988 Jun; 13(3):188-96. PubMed ID: 3136064 [TBL] [Abstract][Full Text] [Related]
8. Utility of 12-lead and signal-averaged Holter electrocardiograms after pilsicainide provocation for risk stratification in Brugada syndrome. Kakihara J; Takagi M; Hayashi Y; Tatsumi H; Doi A; Yoshiyama M Heart Vessels; 2017 Sep; 32(9):1151-1159. PubMed ID: 28364267 [TBL] [Abstract][Full Text] [Related]
9. Differentiation of the electrophysiological effects on the atrial myocardium between the pure Na channel blocker, pilsicainide, and flecainide. Kanemoto M; Shimizu A; Yamagata T; Esato M; Ueyama T; Yoshiga Y; Kakugawa H; Kametani R; Inoue N; Sawa A; Matsuzaki M Cardiovasc Drugs Ther; 2004 Jul; 18(4):295-303. PubMed ID: 15367827 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and electrocardiographic effects of a new controlled-release form of flecainide acetate: comparison with the standard form and influence of the CYP2D6 polymorphism. Tennezé L; Tarral E; Ducloux N; Funck-Brentano C Clin Pharmacol Ther; 2002 Aug; 72(2):112-22. PubMed ID: 12189358 [TBL] [Abstract][Full Text] [Related]
11. [Interactions of quinidine and propranolol with mexiletine, encainide, flecainide and tocainide]. Halawa B Pol Tyg Lek; 1990 Mar 5-12; 45(10-11):222-4. PubMed ID: 2120685 [TBL] [Abstract][Full Text] [Related]
12. Assessment of serum flecainide trough levels in patients with tachyarrhythmia. Homma M; Kuga K; Doki K; Katori K; Yamaguchi I; Sugibayashi K; Kohda Y J Pharm Pharmacol; 2005 Jan; 57(1):47-51. PubMed ID: 15638992 [TBL] [Abstract][Full Text] [Related]
13. Three elderly cases with Brugada-type electrocardiographic pattern unmasked by pilsicainide at the toxic level. Hiasa G; Okayama H; Nishimura K; Sumimoto T Intern Med; 2005 Jan; 44(1):55-9. PubMed ID: 15704664 [TBL] [Abstract][Full Text] [Related]
14. ST segment elevation in the right precordial leads following administration of class Ic antiarrhythmic drugs. Yasuda M; Nakazato Y; Yamashita H; Sekita G; Kawano Y; Mineda Y; Nakazato K; Tokano T; Sumiyoshi M; Nakata Y Heart; 2001 Jan; 85(1):E3. PubMed ID: 11119481 [TBL] [Abstract][Full Text] [Related]
15. Drug therapy: flecainide and tocainide. N Engl J Med; 1987 Feb; 316(6):343-5. PubMed ID: 3100952 [No Abstract] [Full Text] [Related]
16. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia. Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics and pharmacodynamics of class I antiarrhythmic agents after a single oral administration]. Yokota M; Toyama J; Ukai M; Miyahara T; Koide M; Kato R; Yasui S; Sotobata I Jpn Circ J; 1992; 56 Suppl 5():1480-4. PubMed ID: 1291746 [No Abstract] [Full Text] [Related]
18. Comparative Pharmacokinetic and Electrocardiographic Effects of Intratracheal and Intravenous Administration of Flecainide in Anesthetized Pigs. Stocco FG; Evaristo E; Silva AC; de Antonio VZ; Pfeiffer J; Rangachari N; Belardinelli L; Verrier RL J Cardiovasc Pharmacol; 2018 Sep; 72(3):129-135. PubMed ID: 29923887 [TBL] [Abstract][Full Text] [Related]